These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18926576)

  • 21. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
    Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
    Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis.
    Zéphir H; Lefranc D; Dubucquoi S; de Seze J; Boron L; Prin L; Vermersch P
    Mult Scler; 2009 May; 15(5):593-600. PubMed ID: 19299435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
    Valis M; Talab R; Stourac P; Andrys C; Masopust J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engagement of Toll-like receptor 2 on CD4(+) T cells facilitates local immune responses in patients with tuberculous pleurisy.
    Chen X; Zhang M; Zhu X; Deng Q; Liu H; Larmonier N; Graner MW; Zhou B
    J Infect Dis; 2009 Aug; 200(3):399-408. PubMed ID: 19552525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity?
    Genre J; Errante PR; Kokron CM; Toledo-Barros M; Câmara NO; Rizzo LV
    Clin Immunol; 2009 Aug; 132(2):215-21. PubMed ID: 19394278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFalpha, and Granzyme B in CSF.
    Takahashi Y; Mine J; Kubota Y; Yamazaki E; Fujiwara T
    Epilepsia; 2009 Jun; 50(6):1419-31. PubMed ID: 19175398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
    Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
    Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients.
    Varga Z; Csepany T; Papp F; Fabian A; Gogolak P; Toth A; Panyi G
    Immunol Lett; 2009 Jun; 124(2):95-101. PubMed ID: 19409928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta.
    Comi G
    Clin Ther; 2009 Jun; 31(6):1142-57. PubMed ID: 19695384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosis.
    Storek J; Nash RA; McSweeney PA; Furst DE; Sullivan KM
    Clin Immunol; 2006 Oct; 121(1):118-9. PubMed ID: 16844418
    [No Abstract]   [Full Text] [Related]  

  • 32. Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis.
    Cosentino M; Zaffaroni M; Legnaro M; Bombelli R; Schembri L; Baroncini D; Bianchi A; Clerici R; Guidotti M; Banfi P; Bono G; Marino F
    J Neuroimmunol; 2016 Sep; 298():82-9. PubMed ID: 27609280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients.
    Kindlund B; Sjöling A; Hansson M; Edebo A; Hansson LE; Sjövall H; Svennerholm AM; Lundin BS
    Helicobacter; 2009 Jun; 14(3):192-201. PubMed ID: 19702849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-beta treatment?
    Drulovic J; Savic E; Pekmezovic T; Mesaros S; Stojsavljevic N; Dujmovic-Basuroski I; Kostic J; Vasic V; Mostarica Stojkovic M; Popadic D
    J Neuroimmunol; 2009 Oct; 215(1-2):90-5. PubMed ID: 19695714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of CD4+CD25+Foxp3+ regulatory T cells in patients of haemorrhagic fever with renal syndrome].
    Nie ST; Li Q; Wang HY
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):817-9. PubMed ID: 19595120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-box 21 transcription factor is responsible for distorted T(H)2 differentiation in human peripheral CD4+ T cells.
    Kaminuma O; Kitamura F; Miyatake S; Yamaoka K; Miyoshi H; Inokuma S; Tatsumi H; Nemoto S; Kitamura N; Mori A; Hiroi T
    J Allergy Clin Immunol; 2009 Apr; 123(4):813-23.e3. PubMed ID: 19348920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
    Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M
    J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.
    Desai F; Ramanathan M; Fink CS; Wilding GE; Weinstock-Guttman B; Awad AB
    Int Immunopharmacol; 2009 Jan; 9(1):153-7. PubMed ID: 19022404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.